| scholarly article | Q13442814 |
| P50 | author | Yuetsu Tanaka | Q66386565 |
| P2093 | author name string | Yoshio Koyanagi | |
| Naoko Misawa | |||
| Kei Sato | |||
| Mamoru Ito | |||
| Chuanyi Nie | |||
| P2860 | cites work | CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract | Q22242965 |
| Development of functional human blood and immune systems in NOD/SCID/IL2 receptor {gamma} chain(null) mice | Q24669724 | ||
| NOD/SCID/gamma(c)(null) mouse: an excellent recipient mouse model for engraftment of human cells | Q28207942 | ||
| Humanized NOD/SCID/IL2Rgamma(null) mice transplanted with hematopoietic stem cells under nonmyeloablative conditions show prolonged life spans and allow detailed analysis of human immunodeficiency virus type 1 pathogenesis | Q28756080 | ||
| The dendritic cell system and its role in immunogenicity | Q29619870 | ||
| Human immunodeficiency virus type 1 strains R5 and X4 induce different pathogenic effects in hu-PBL-SCID mice, depending on the state of activation/differentiation of human target cells at the time of primary infection. | Q33816889 | ||
| The human immunodeficiency virus: infectivity and mechanisms of pathogenesis | Q34049376 | ||
| Rodent models for HIV-1 infection and disease | Q35713541 | ||
| Isoforms of the CD45 common leukocyte antigen family: markers for human T-cell differentiation | Q35868451 | ||
| Progressive CD4+ central memory T cell decline results in CD4+ effector memory insufficiency and overt disease in chronic SIV infection | Q36229666 | ||
| Constant mean viral copy number per infected cell in tissues regardless of high, low, or undetectable plasma HIV RNA. | Q36369965 | ||
| Experimental models to study development and function of the human immune system in vivo | Q36385564 | ||
| Modulation of human immunodeficiency virus type 1 infectivity through incorporation of tetraspanin proteins | Q36424527 | ||
| T cell immune responses to HIV-1. | Q36664081 | ||
| Cellular responses to viral infection in humans: lessons from Epstein-Barr virus. | Q36766875 | ||
| The SCID-hu mouse: a small animal model for HIV infection and pathogenesis | Q37357883 | ||
| Human immunodeficiency virus infection of human lymph nodes in the SCID-hu mouse | Q37517923 | ||
| Interleukin-4-transgenic hu-PBL-SCID mice: a model for the screening of antiviral drugs and immunotherapeutic agents against X4 HIV-1 viruses | Q39320904 | ||
| Expanded tropism of primary human immunodeficiency virus type 1 R5 strains to CD4(+) T-cell lines determined by the capacity to exploit low concentrations of CCR5. | Q39551157 | ||
| Hematopoietic stem cell-engrafted NOD/SCID/IL2Rgamma null mice develop human lymphoid systems and induce long-lasting HIV-1 infection with specific humoral immune responses | Q39580500 | ||
| Complete reconstitution of human lymphocytes from cord blood CD34+ cells using the NOD/SCID/γcnull mice model | Q40656354 | ||
| Humanized mice: are we there yet? | Q42972285 | ||
| In HIV-1 pathogenesis the die is cast during primary infection | Q43716538 | ||
| Thymus-independent T-cell differentiation in vitro | Q43875695 | ||
| A new humanized mouse model of Epstein-Barr virus infection that reproduces persistent infection, lymphoproliferative disorder, and cell-mediated and humoral immune responses | Q43939988 | ||
| Human immunodeficiency virus infection of human-PBL-SCID mice | Q45853273 | ||
| Development of a human adaptive immune system in cord blood cell-transplanted mice | Q47819239 | ||
| Adapted NOD/SCID model supports development of phenotypically and functionally mature T cells from human umbilical cord blood CD34(+) cells | Q49051187 | ||
| Monitoring the effect of gene silencing by RNA interference in human CD34+ cells injected into newborn RAG2-/- gammac-/- mice: functional inactivation of p53 in developing T cells. | Q53888112 | ||
| Dual infection of the central nervous system by AIDS viruses with distinct cellular tropisms. | Q55487007 | ||
| Identification of human T-lymphoid progenitor cells in CD34+CD38low and CD34+CD38+ subsets of human cord blood and bone marrow cells using NOD-SCID fetal thymus organ cultures | Q58125714 | ||
| Infection of the SCID-hu mouse by HIV-1 | Q67985380 | ||
| A unified theory of central tolerance in the thymus | Q83036352 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | lymphocyte | Q715347 |
| HIV | Q15787 | ||
| P304 | page(s) | B32-7 | |
| P577 | publication date | 2010-05-01 | |
| P1433 | published in | Vaccine | Q7907941 |
| P1476 | title | Dynamics of memory and naïve CD8+ T lymphocytes in humanized NOD/SCID/IL-2Rgammanull mice infected with CCR5-tropic HIV-1. | |
| P478 | volume | 28 Suppl 2 |
| Q34352429 | APOBEC3D and APOBEC3F potently promote HIV-1 diversification and evolution in humanized mouse model |
| Q38043556 | Animal models in virus research: their utility and limitations |
| Q38765734 | Anti-HIV-1 potency of the CRISPR/Cas9 system insufficient to fully inhibit viral replication |
| Q37195155 | Can humanized mice reflect the complex pathobiology of HIV-associated neurocognitive disorders? |
| Q33577361 | Current advances in humanized mouse models |
| Q34474320 | Current humanized mouse models for studying human immunology and HIV-1 immuno-pathogenesis |
| Q87056737 | Development of human B cells and antibodies following human hematopoietic stem cell transplantation to Rag2(-/-)γc(-/-) mice |
| Q46246548 | Experimental adaptive evolution of SIVcpz to pandemic HIV-1 using a humanized mouse model |
| Q36056241 | Experimental evaluation of the zoonotic infection potency of simian retrovirus type 4 using humanized mouse model. |
| Q64104899 | HIV Replication in Humanized IL-3/GM-CSF-Transgenic NOG Mice |
| Q35067233 | HIV-1 Vpr accelerates viral replication during acute infection by exploitation of proliferating CD4+ T cells in vivo |
| Q33699581 | HIV-1 competition experiments in humanized mice show that APOBEC3H imposes selective pressure and promotes virus adaptation |
| Q37676228 | HIV-1 immunopathogenesis in humanized mouse models |
| Q50146682 | Humanized Mice as Unique Tools for Human-Specific Studies |
| Q38787325 | Humanized NOG mice as a model for tuberculosis vaccine-induced immunity: a comparative analysis with the mouse and guinea pig models of tuberculosis. |
| Q37111994 | Humanized mice for immune system investigation: progress, promise and challenges |
| Q40548525 | Humanized mouse as an appropriate model for accelerated global HIV research and vaccine development: current trend |
| Q37089865 | Humanized mouse models of HIV infection |
| Q37254488 | Humoral immunity in humanized mice: a work in progress |
| Q37467601 | Improved B cell development in humanized NOD-scid IL2Rγnull mice transgenically expressing human stem cell factor, granulocyte-macrophage colony-stimulating factor and interleukin-3 |
| Q36601983 | Improvements and Limitations of Humanized Mouse Models for HIV Research: NIH/NIAID "Meet the Experts" 2015 Workshop Summary |
| Q34920166 | Mice with human immune system components as in vivo models for infections with human pathogens |
| Q35921136 | Modeling HIV-associated neurocognitive disorders in mice: new approaches in the changing face of HIV neuropathogenesis |
| Q27014786 | New generation humanized mice for virus research: comparative aspects and future prospects |
| Q37900419 | The mouse is out of the bag: insights and perspectives on HIV-1-infected humanized mouse models |
| Q35206268 | The utility of the new generation of humanized mice to study HIV-1 infection: transmission, prevention, pathogenesis, and treatment |
| Q35943823 | Vpu augments the initial burst phase of HIV-1 propagation and downregulates BST2 and CD4 in humanized mice |
Search more.